Roggwil, February 2, 2021 – In October 2020, work began on a new packaging for the tinniwell. This became necessary because, due to increased sales, the old model was too time-consuming in assembly. The new packaging is significantly more stable than the predecessor version, and our product is presented to the customer in a much more valuable way. After opening the packaging, the patient is now presented with the tinnitus therapy device, including its accessories, "at a glance." Due to its new design, the packaging can now also be used internationally, and no country-specific packaging needs to be produced. Delivery in the new design will begin in March 2021.

++ About Resaphene Suisse AG

Resaphene Suisse AG, based in Roggwil, Switzerland, is a medical technology company that was founded in 2015 and has been selling a tinnitus therapy device under the name tinniwell since 2016. Other distribution companies include Resaphene Deutschland GmbH in Constance, Resaphene UK Ltd. in London, and Resaphene US LLC in the USA.

++ Contact for inquiries:

Resaphene Suisse AG
Ms. Anke Rauterkus (Chief Executive Officer)
Bahnhofplatz 5
9322 Egnach
Switzerland
T. +41 714500668
a.rauterkus@resaphene.ch